HDAC 抑制剂:用于白血病治疗的有前途的药物
Yun Deng1, Qian Cheng2, Jing He1
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Biochemical and biophysical research communications
|September 18, 2023
概括
激素脱乙酶抑制剂 (HDACi) 是有前途的抗癌药物,特别是在白血病中. 本综述探讨了它们的机制和在治疗血液癌症中的临床用途.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 表观遗传修饰,包括基因组脱乙酶 (HDAC) 活性,在癌症发育中至关重要.
- 异常的HDAC表达在各种癌症类型中很常见,使HDAC成为治疗点.
- HDAC 抑制剂 (HDACi) 提供了一个有前途的治疗策略,而 vorinostat 是 FDA 批准的第一个用于皮肤T细胞淋巴瘤的 HDACi.
研究的目的:
- 审查HDAC抑制剂在癌症中发挥治疗效益的机制.
- 讨论HDAC抑制剂的临床实用性,重点关注它们在白血病治疗中的应用.
- 突出HDAC抑制剂作为抗白血病药物的潜力.
主要方法:
- 对表观遗传修饰和HDAC抑制剂研究的文献综述.
- 对已批准和正在研究的HDAC抑制剂的临床试验数据的分析.
- 检查支持白血病中HDAC抑制的临床前和临床证据.
主要成果:
- HDAC 抑制剂表现出多种抗癌机制,包括促进细胞灭绝和抑制增殖.
- 涉及HDAC抑制剂和化疗药物的组合疗法正在积极研究中,特别是在血液性恶性瘤中.
- 在临床试验中已经评估了20多种HDAC抑制剂,其中5种获得了监管批准.
结论:
- HDAC 抑制剂代表了瘤学的重大治疗进步.
- 它们的多方面的抗癌作用使它们成为白血病治疗的有价值药物.
- 对HDAC抑制机制和临床应用的进一步研究有望改善患者的治疗结果.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:22Bone Marrow Sampling and Transplants
356
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
356
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
460
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460
01:25Antihypertensive Drugs: Direct Renin Inhibitors
677
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
677